Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|June 8, 2026
Patient preferences and willingness-to-pay for therapy in generalized myasthenia gravis: a large-scale discrete choice experiment in ChinaYafang Xu, Ling Feng, Mingjie Zhang, et al.
European Journal of Neurology|April 10, 2022
Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorderWenjuan Huang, Liang Wang, Junhui Xia, et al.
Therapeutic Advances in Neurological Disorders|March 2, 2023
Short-term outcome prediction for myasthenia gravis: an explainable machine learning modelHuahua Zhong, Zhe Ruan, Chong Yan, et al.
Neurocritical Care|August 28, 2025
The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care UnitHongxi Chen, Yuan Wang, Nana Zhang, et al.
Muscle & Nerve|April 1, 2024
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopeniaKexin Jiao, Nachuan Cheng, Xiao Huan, et al.
Therapeutic Advances in Neurological Disorders|September 2, 2017
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in ChinaLei Zhou, Weibin Liu, Wei Li, et al.
Annals of Clinical and Translational Neurology|July 8, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in ChinaSushan Luo, Qilong Jiang, Wenshuang Zeng, et al.
Orphanet Journal of Rare Diseases|March 8, 2024
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1Huahua Zhong, Li Zeng, Xuefan Yu, et al.
Journal of Oleo Science|January 4, 2026
Treatment of Ulcerative Colitis with Myrrh Essential Oil MicroemulsionMengmeng Wang, Tiantian Tang, Mei Liu, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
Pageof 22